Abstract: Aspects of the application provide anti-hemojuvelin antibodies and methods of using the same in treating anemias of chronic disease, iron-restricted anemias, and/or conditions associated with anemia.

Abstract: A ?-Ga2O3 layer is grown on a substrate by: performing a first deposition cycle at a first growth rate using oxygen and a precursor including Ga, the first deposition cycle having a thickness of at least 3 atomic layers of ?-Ga2O3 and at most 20 atomic layers of ?-Ga2O3; determining a regression curve for a layer surface reflectivity using tuples of a measured first layer surface reflectivity and having a first layer thickness; and performing a second deposition cycle including measuring a second layer thickness and a second layer surface reflectivity, with a predetermined second growth rate determined from the first growth rate multiplied by a correction factor, having a defined lower and upper limit.

Abstract: Aspects of the application provide anti-hemojuvelin antibodies and methods of using the same in treating myelofibrosis and/or conditions associated with myelofibrosis.

Abstract: A semiconductor component for emitting light includes a main body that comprises at least one mesa body. The mesa body has an emission region for emitting the light. The emission region is assigned a first mirror portion, a second mirror portion, and an active portion arranged between the two mirror portions and serving to produce the light. The semiconductor component further includes electrical contacts for feeding electrical energy into the active portion, with at least one stress element that is attached to a surface of the main body. The stress element is configured to generate in the main body a material stress which has an effect on one or more polarization properties of the emitted light.

Abstract: Aspects of the application provide anti-hemojuvelin antibodies and methods of using the same in treating myelofibrosis and/or conditions associated with myelofibrosis.

Abstract: Aspects of the application provide anti-hemojuvelin antibodies and methods of using the same in treating myelofibrosis and/or conditions associated with myelofibrosis.

Abstract: Aspects of the application provide anti-hemojuvelin antibodies and methods of using the same in treating myelofibrosis and/or conditions associated with myelofibrosis.

Abstract: A system for measuring the presence and/or the concentration of an analysis substance dissolved in a bodily fluid includes a light source configured to emit excitation light and an optical device. The optical device defines, for the excitation light, an excitation beam path from the light source to a measurement region of a sample and, for scattered light from the measurement region of the sample, a detection beam path from the measurement region of the sample to a detection device. The system also includes a detection device configured to detect the scattered light. The detection device includes a light-sensitive sensor and a filter element arranged in the detection beam path, the filter element being designed to suppress a transmission of light with wavelengths outside of an analysis wavelength range around a Raman resonance of the analysis substance.

Abstract: Aspects of the application provide anti-hemojuvelin antibodies and methods of using the same in treating myelofibrosis and/or conditions associated with myelofibrosis.

Abstract: Aspects of the application provide anti-hemojuvelin antibodies and methods of using the same in treating myelofibrosis and/or conditions associated with myelofibrosis.

Abstract: A device for determining a glucose concentration in an anterior chamber of a user's eye includes a VCSEL which emits laser light, and an optical element for influencing the laser light and/or an emergent light. The VCSEL and the optical element are configured such that the laser light enters the anterior chamber of the eye. The emergent light from the anterior chamber penetrates into the VCSEL. The device further includes an analysis unit that analyses a resulting self-mixing interference within the VCSEL to determine the glucose concentration.

Abstract: Provided herein are methods of using the antibodies that bind to RGMc to treat and diagnose iron-related disorders.

Abstract: Aspects of the application provide anti-hemojuvelin antibodies and methods of using the same in treating myelofibrosis and/or conditions associated with myelofibrosis.

Abstract: The invention relates to a method for embossing a channel structure (3) comprising a plurality of parallel channel portions (5) in a planar metal sheet (11) to form a half-plate (2, 2?), in particular for a bipolar plate (1) of an electrochemical cell, said method having the following steps: providing the planar metal sheet (11) with a uniform initial wall thickness (d5), inserting the metal sheet (11) into a forming tool (12), wherein a base plane (BE) of the sheet (11) defined by the undeformed planar metal sheet (11) is provided to rest on a tool plane defined by a tool part (13) of the forming tool (12), forming the plurality of channel portions (5), each channel portion (5) being designed with two non-parallel flanks (7, 8) in such a way as to allow material from embossing portions (9, 10) of the metal sheet (11), which are located outside the flanks and remain in the base plane (BE) and/or a plane parallel thereto throughout the entire forming process, to be displaced into the flanks (7, 8), each fla

Abstract: Aspects of the application provide hemojuvelin antagonists and methods of using the same in treating anemias of kidney disease and conditions associated with these anemias. Methods provided in the application relate to treatment of a subject having an anemia associated with chronic kidney disease and/or kidney disease in a subject that has a level of glomerular filtration rate lower than one or more thresholds.

Abstract: A laser amplifier includes a laser-active solid-state rod, through which an input laser beam passes at least twice, and a pump device for generating at least one pump laser beam which is incoupled into the solid-state rod via a first end face of the solid-state rod in order to optically pump the solid-state rod. The input laser beam is incoupled into the solid-state rod via a second end face of the solid-state rod. The input laser beam amplified in the solid-state rod is outcoupled from the solid-state rod in order to form an output laser beam. The laser amplifier further includes a dichroic mirror arranged in a beam path of the pump laser beam between the solid-state rod and the pump device and at an right angle to the pump laser beam. The dichroic mirror is transmissive for the pump laser beam and reflective for the input laser beam.

Abstract: Provided herein are methods of using the antibodies that bind to RGMc to treat and diagnose iron-related disorders.

Abstract: Provided herein are methods of using the antibodies that bind to RGMc to treat and diagnose iron-related disorders.

Abstract: A ?-Ga2O3 layer is grown on a substrate by: performing a first deposition cycle at a first growth rate using oxygen and a precursor including Ga, the first deposition cycle having a thickness of at least 3 atomic layers of ?-Ga2O3 and at most 20 atomic layers of ?-Ga2O3; determining a regression curve for a layer surface reflectivity using tuples of a measured first layer surface reflectivity and having a first layer thickness; and performing a second deposition cycle including measuring a second layer thickness and a second layer surface reflectivity, with a predetermined second growth rate determined from the first growth rate multiplied by a correction factor, having a defined lower and upper limit.

Abstract: Provided herein are methods of using the antibodies that bind to RGMc to treat and diagnose iron-related disorders.